Rising research and development(R&D) initiatives in the pharma sector has made India a more mature place for drug discovery activities than China, says a report. Further, the report prepared by US-based Ewing Marion Kauffman Foundation noted that Indian companies are playing a strategic role in early drug discovery processes due to their vast experience in the field of generic drugs. India is regarded as a more mature venue for chemistry and drug discovery activities than China, the study titled